PYC Therapeutics LimitedASX: PYC

ADOA Program - Data Presentation

· Issued by PYC Therapeutics Limited via ASX

Filed with ASX ·

pyctx.com | ACN 098 391 961 1 3 September 2026 ADOA PROGRAM - DATA PRESENTATION AT NOSA 2026 • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug...

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

In the deck

Earlier from PYC Therapeutics

Later from PYC Therapeutics

All PYC Therapeutics news releases